lipoatrophy

patients with hiv often experience lipoatrophy, particularly in the face and limbs.

lipoatrophy can significantly impact a patient's self-esteem and body image.

the development of lipoatrophy is a known side effect of long-term protease inhibitor use.

early detection of lipoatrophy allows for proactive management and potential interventions.

lipoatrophy treatment options include lifestyle modifications and pharmacological interventions.

severe lipoatrophy can lead to metabolic complications and other health issues.

researchers are investigating the underlying mechanisms of lipoatrophy to develop targeted therapies.

lipoatrophy presents a significant challenge in managing hiv-related complications.

the incidence of lipoatrophy has decreased with the introduction of newer antiretroviral drugs.

monitoring for lipoatrophy is a crucial part of hiv patient care.

lipoatrophy can manifest as facial wasting and limb contour changes.